Skip to main content
Thorax logoLink to Thorax
. 1996 Nov;51(11):1073. doi: 10.1136/thx.51.11.1073

Risk of severe life threatening asthma.

N C Barnes, L M Kuitert
PMCID: PMC1090514  PMID: 8958886

Full text

PDF

Page 1073

1073

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beasley R., Burgess C., Crane J., Pearce N. A review of the studies of the asthma mortality epidemic in New Zealand. Allergy Proc. 1995 Jan-Feb;16(1):27–32. doi: 10.2500/108854195778690075. [DOI] [PubMed] [Google Scholar]
  2. Beasley R., Burgess C., Pearce N., Woodman K., Crane J. Confounding by severity does not explain the association between fenoterol and asthma death. Clin Exp Allergy. 1994 Jul;24(7):660–668. doi: 10.1111/j.1365-2222.1994.tb00970.x. [DOI] [PubMed] [Google Scholar]
  3. Crane J., Pearce N., Flatt A., Burgess C., Jackson R., Kwong T., Ball M., Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet. 1989 Apr 29;1(8644):917–922. doi: 10.1016/s0140-6736(89)92505-1. [DOI] [PubMed] [Google Scholar]
  4. Garrett J. E., Lanes S. F., Kolbe J., Rea H. H. Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity. Thorax. 1996 Nov;51(11):1093–1099. doi: 10.1136/thx.51.11.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Grainger J., Woodman K., Pearce N., Crane J., Burgess C., Keane A., Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax. 1991 Feb;46(2):105–111. doi: 10.1136/thx.46.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jackson R. T., Beaglehole R., Rea H. H., Sutherland D. C. Mortality from asthma: a new epidemic in New Zealand. Br Med J (Clin Res Ed) 1982 Sep 18;285(6344):771–774. doi: 10.1136/bmj.285.6344.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lipworth B. J., Newnham D. M., Clark R. A., Dhillon D. P., Winter J. H., McDevitt D. G. Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients. Thorax. 1995 Jan;50(1):54–61. doi: 10.1136/thx.50.1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Pearce N., Grainger J., Atkinson M., Crane J., Burgess C., Culling C., Windom H., Beasley R. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax. 1990 Mar;45(3):170–175. doi: 10.1136/thx.45.3.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sears M. R., Rea H. H., Beaglehole R., Gillies A. J., Holst P. E., O'Donnell T. V., Rothwell R. P., Sutherland D. C. Asthma mortality in New Zealand: a two year national study. N Z Med J. 1985 Apr 24;98(777):271–275. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES